AudiologyOnline Phone: 800-753-2160


CareCredit Loans - May 2024

MED-EL Announces FDA Approval for the New Rechargeable DaCapo Battery and Charging System

Share:
Durham, NC - (May 19, 2008) - MED-EL has received approval by the US Food and Drug Administration for its new rechargeable DaCapo battery and charging system.


The DaCapo system was developed for the MED-EL OPUS 1, OPUS 2 and TEMPO+ speech processors. MED-EL speech processors continue to be the lightest and slimmest available. The DaCapo system additionally reduces the weight by another 20% without limiting performance.

DaCapo is an environmentally friendly and very convenient alternative to the existing battery options. The system is shipped with a charging unit and three PowerPacks, rechargeable batteries each lasting for 10-12 hours. It is compatible with most FM systems and other external hearing devices (e.g. Bluetooth® with OPUS 2). DaCapo is available in all six frame colors for a perfect match with existing MED-EL speech processor colors.

About MED-EL Corporation

Since its founders developed one of the world's first cochlear implants in 1975, MED-EL has set new standards in hearing implant technologies, developing and manufacturing technologically advanced hearing solutions for people with varying degrees of hearing loss. MED-EL hearing implant systems, currently used in 70 countries, combines the latest scientific advances, engineering and manufacturing techniques for performance, safety and reliability. For more information, visit www.medel.com or call 888-MED-EL-CI (633-3524).
Need 2025 ethics hours? Explore available courses and start earning now! View courses

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.